An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …
Post-traumatic stress symptoms in healthcare workers dealing with the COVID-19 pandemic: a systematic review
Prevention of post-traumatic stress symptoms (PTSS) in healthcare workers (HCWs) facing
the current COVID-19 pandemic is a challenge worldwide as HCWs are likely to experience …
the current COVID-19 pandemic is a challenge worldwide as HCWs are likely to experience …
[HTML][HTML] Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19)
A Aleem, AS Ab, AK Slenker - 2021 - europepmc.org
Objectives: Describe the clinical manifestations, including extrapulmonary manifestations of
COVID-19. Outline the latest treatments available in the management of COVID-19 …
COVID-19. Outline the latest treatments available in the management of COVID-19 …
COVID-19 vaccine acceptance and beliefs among Black and Hispanic Americans
K Kricorian, K Turner - PloS one, 2021 - journals.plos.org
The introduction of COVID-19 vaccines is a major public health breakthrough. However,
members of US Black and Hispanic communities, already disproportionately affected by the …
members of US Black and Hispanic communities, already disproportionately affected by the …
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape
D Tian, YH Sun, JM Zhou, Q Ye - Journal of medical virology, 2022 - Wiley Online Library
During the COVID‐19 pandemic, genetic variants of SARS‐CoV‐2 have been emerging and
spreading around the world. Several SARS‐CoV‐2 endemic variants were found in United …
spreading around the world. Several SARS‐CoV‐2 endemic variants were found in United …
[HTML][HTML] Delta variant: the new challenge of COVID-19 pandemic, an overview of epidemiological, clinical, and immune characteristics
The SARS-CoV-2 genome has undergone several mutations since the beginning of the
pandemic in December 2019. A number of these mutants were associated with higher …
pandemic in December 2019. A number of these mutants were associated with higher …
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
W Sun, L He, H Zhang, X Tian, Z Bai, L Sun… - Signal transduction and …, 2021 - nature.com
As COVID-19 continues to spread rapidly worldwide and variants continue to emerge, the
development and deployment of safe and effective vaccines are urgently needed. Here, we …
development and deployment of safe and effective vaccines are urgently needed. Here, we …
[HTML][HTML] 新型冠状病毒Delta 变异株引起的广州市荔湾区本土疫情流行特征分析
李文艳， 杜志成， 王莹， 林晓， 陆龙， 方强， 张万方… - 中华流行病学 …, 2021 - html.rhhz.net
目的分析新型冠状病毒(新冠病毒) B. 1.617. 2 (Delta) 变异株引起的广州市荔湾区本土疫情流行
特征, 为Delta 变异株疫情防控工作提供参考依据. 方法资料来源于中国疾病预防控制信息系统 …
特征, 为Delta 变异株疫情防控工作提供参考依据. 方法资料来源于中国疾病预防控制信息系统 …
Brief review of the mRNA vaccines COVID-19
A Vitiello, F Ferrara - Inflammopharmacology, 2021 - Springer
The global COVID-19 pandemic continues to claim victims worldwide, representing a health
and socioeconomic challenge with few precedents in human history. The therapeutic agents …
and socioeconomic challenge with few precedents in human history. The therapeutic agents …
新型冠状病毒Omicron 变异株的流行病学特征及防控研究
吴俣， 刘珏， 刘民， 梁万年 - 中国全科医学, 2022 - chinagp.net
Omicron (B. 1.1. 529) 变异株于2021 年11 月24 日首次从南非报告给世界卫生组织, 截至2021
年12 月8 日全球共有57 个国家和地区报告了Omicron 感染病例. 目前Omicron …
年12 月8 日全球共有57 个国家和地区报告了Omicron 感染病例. 目前Omicron …